COMP <GO>
COR vs MRK // GROSS PROFIT MARGIN
Cencora Inc. (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: COR 5
— MRK 10
▲ GROSS PROFIT MARGIN LEADER: MRK
LAST: $330.84 (+0.09%) • MKT CAP: $63.07B
gross-margins
3.60%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
gross-margins
74.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COR VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COR | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 3.60% | 74.80% | -71.20 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 26.80% | 20.70% | +6.10 | COR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.6x | 15.3x | +6.30 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 5.08% | 3.42% | +1.66 | COR | /fcf-yield <GO> |
| Operating Margin | 0.80% | 34.30% | -33.50 | MRK | /operating-margins <GO> |
| Net Profit Margin | 0.50% | 28.10% | -27.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 9.30% | 1.30% | +8.00 | COR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.69% | 2.26% | -1.57 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.27 | 5.19 | +0.08 | COR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.60% | -0.10 | COR | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 56.9 | -2.72 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.92 | -0.04 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 37.8x | 18.4x | +19.40 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $63.07B | $361.02B | -$297.95B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COR REV | MRK REV | COR GROSS % | MRK GROSS % | COR FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $321.33B | $65.01B | 3.6% | 74.8% | $3.21B | $12.36B |
| FY 2024 | $293.96B | $64.17B | 3.4% | 76.3% | $3.00B | $18.10B |
| FY 2023 | $262.17B | $60.12B | 44.0% | 44.0% | -$7.89B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COR // BETA 0.88
MRK // BETA 0.92